Sino US Health Cooperation Forum Series - Central South University Xiangya Hospital

• by EVOMT
• 2019-07-05

On June 24th, the special event of the Sino US Health Cooperation Forum (VI) jointly organized by Aiwo Hospital and Xiangya Hospital of Central South University (hereinafter referred to as Xiangya Hospital) was successfully held in Xiangya Hospital. Ms. Wu Qiuting, CEO of Aiwo Medical, David C. Read, Vice President of Dana Faber Cancer Research Institute affiliated to Harvard Medical School, Zhang Xin, Secretary of the Hospital's Party Committee, Li Xuejun, Director of the International Cooperation and Exchange Office, hospital related discipline backbones, Aiwo staff, and others participated in the meeting.

Secretary Zhang Xin briefed Professor David on the history, development status, and strengths of Xiangya Hospital. He said that as a product of Sino US medical cooperation, Xiangya Hospital has always attached great importance to international exchanges and cooperation, and hopes to take this special event as an opportunity to carry out various forms of exchanges and cooperation with Dana Faber Cancer Research Institute in the future.

The meeting was chaired by Sun Lunquan, Director of the Molecular Medicine Research Center of Central South University (Xiangya Hospital), and Professor David presented a speech entitled "" Overview of a Top-Rated U.S. Cancer Center" An academic report. Shen Liangfang, Director of the Oncology Department of Xiangya Hospital, Zeng Shan, Deputy Director and Director of the Tumor Chemotherapy Department, and several medical and nursing personnel, scientific research personnel, advanced students, and graduate students from the department waited to listen, and interacted with Professor David.